a new form of inherited thrombocytopenia: etv6, never judge a book by its cover
Published 8 years ago • 340 plays • Length 3:47Download video MP4
Download video MP3
Similar videos
-
3:17
thrombopoietin receptor agonists in itp: current status and future outlooks
-
1:54
fostamatinib and efgartigimod: novel agents in the treatment of itp
-
2:03
unmet needs in immune thrombocytopenia
-
1:34
advances and unmet needs in second-line treatment of dlbcl
-
1:09
emerging treatment options for refractory immune thrombocytopenia
-
17:31
expanding chb treatment criteria with nucs as prelude of novel (...) ? - harry janssen, md, phd
-
1:06:04
itp: novel treatments
-
27:03
m-35.nano encapsulation
-
1:39
the mechanism of action of navtemadlin and its role in mf
-
2:36
a cd38-targeting bispecific antibody in the treatment of r/r t-all
-
2:13
current and emerging treatment options for patients with mf who are ineligible for ruxolitinib
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:18
hematology, 6th edition
-
2:24
comparing allosct outcomes in secondary and de-novo acute lymphoblastic leukemia
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
3:26
the risk of thrombotic events in patients with mgus: an analysis from the istopmm trial
-
2:26
an insight into the aims of the eurasian hematology-oncology group
-
1:54
fusion-aml-001: molecular changes associated with azacitidine & durvalumab in tp53m aml and hr-mds
-
1:31
pembrolizumab plus avd in chl: long-term follow-up of a phase ii study
-
4:48
an insight into the management of cytopenias in mf
-
1:36
are novel therapeutics replacing asct?
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml